NCT06322810

Brief Summary

This clinical trial compares analgesia efficiency and recovery outcomes between two different fascial plane block techniques (ESPB vs.PIFB) in cardiac surgery patients participant population/health conditions\]. The main questions it aims to answer are:

  • Does ESPB provide superior analgesia than PIFB
  • Do patients who receive ESPB have better recovery outcomes

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Nov 2024Dec 2026

First Submitted

Initial submission to the registry

March 10, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 21, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

November 8, 2024

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

2.1 years

First QC Date

March 10, 2024

Last Update Submit

February 22, 2026

Conditions

Keywords

Erector spinae plane blockPecto-intercostal plane blockCardiac surgery

Outcome Measures

Primary Outcomes (1)

  • 48hr opioid consumption

    The primary outcome of this study was the total oral morphine equivalent (OME) dose received within 48 hours after surgery. OME was calculated using a conversion toolkit within our hospital's electronic medical record system, which standardizes opioid analgesic doses to oral morphine equivalents according to established guidelines

    Day 2

Secondary Outcomes (12)

  • Postoperative static pain scores-Day 1

    Day 1

  • Postoperative static pain scores-Day 2

    Day 2

  • Postoperative dynamic pain scores-Day 1

    Day 1

  • Postoperative dynamic pain scores-Day 2

    Day 2

  • postoperative incentive spirometry volume (ml)-Day 1

    Day 1

  • +7 more secondary outcomes

Study Arms (2)

Group E

EXPERIMENTAL

Patients who receive erector spinae plane block(ESPB) before cardiac surgery

Procedure: Erector spinae plane block (ESPB)

Group P

ACTIVE COMPARATOR

Patients who receive Pecto-intercostal plane block(PIFB) before cardiac surgery

Procedure: Pecto-intercostal fascial plane blok (PIFB)

Interventions

Bilateral ESP: 0.5% ropivacaine 0.3 ml per kg (ideal body weight) each side, 30 min before skin excision. After surgery, use pump to deliver an intermittent automatic bolus of 0.3 ml per kg 0.16% ropivacaine every 4 hours each side.

Group E

Bilateral PIFB: 0.5% ropivacaine 0.3 ml per kg (ideal body weight) each side, 30 min before skin excision. After surgery, use pump to deliver an intermittent automatic bolus of 0.3 ml per kg 0.16% ropivacaine every 4 hours each side.

Group P

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults patients, elective and first-time cardiac surgery patients undergoing traditional sternotomy. Procedures include coronary artery bypass surgery, valve repair or replacement surgery, atrial and ventricular septal defect repair surgery, and other open-heart surgeries.

You may not qualify if:

  • \. Emergency surgery 2. Anticipated combined major aortic vascular surgery 3. Already admitted to the ICU or on a ventilator before surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taichung Veterans General Hospital

Taichung, Taiwan, 407, Taiwan

RECRUITING

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Yi-Ting Chang, Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Attending Anesthesiologist

Study Record Dates

First Submitted

March 10, 2024

First Posted

March 21, 2024

Study Start

November 8, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

February 24, 2026

Record last verified: 2026-02

Locations